ATE180251T1 - Indan derivate und verfahren zu deren herstellung - Google Patents

Indan derivate und verfahren zu deren herstellung

Info

Publication number
ATE180251T1
ATE180251T1 AT94120687T AT94120687T ATE180251T1 AT E180251 T1 ATE180251 T1 AT E180251T1 AT 94120687 T AT94120687 T AT 94120687T AT 94120687 T AT94120687 T AT 94120687T AT E180251 T1 ATE180251 T1 AT E180251T1
Authority
AT
Austria
Prior art keywords
group
production
lower alkyl
alkyl group
indan derivatives
Prior art date
Application number
AT94120687T
Other languages
German (de)
English (en)
Inventor
Akihiko Ishida
Koichi Homma
Michihisa Yato
Shinsuke Nishiyama
Fumikazu Okumura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE180251T1 publication Critical patent/ATE180251T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94120687T 1993-12-28 1994-12-27 Indan derivate und verfahren zu deren herstellung ATE180251T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33525093 1993-12-28

Publications (1)

Publication Number Publication Date
ATE180251T1 true ATE180251T1 (de) 1999-06-15

Family

ID=18286423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94120687T ATE180251T1 (de) 1993-12-28 1994-12-27 Indan derivate und verfahren zu deren herstellung

Country Status (11)

Country Link
US (1) US5686452A (zh)
EP (1) EP0661273B1 (zh)
KR (1) KR950017968A (zh)
CN (1) CN1107844A (zh)
AT (1) ATE180251T1 (zh)
CA (1) CA2138812A1 (zh)
DE (1) DE69418582D1 (zh)
DK (1) DK0661273T3 (zh)
MX (1) MX9500251A (zh)
SG (1) SG48755A1 (zh)
TW (1) TW288012B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co History of pyridazinone and processes for their preparation
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP2328586A2 (en) * 2008-05-20 2011-06-08 Cephalon, Inc. Substituted pyridazinone derivatives as histamine-3 (h3) receptor ligands

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
EP0194548A3 (de) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Neue Sulfonylaminoäthylverbindungen, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL88314A (en) * 1987-11-18 1994-05-30 Tanabe Seiyaku Co History of sulfonylamino indane, their preparation and pharmaceutical preparations containing them
DE69211133T2 (de) * 1991-03-01 1996-10-31 Zeria Pharmaceutical Co., Ltd., Tokio/Tokyo Indan-derivate als thromboxan-antagonisten
CA2099743A1 (en) * 1992-07-02 1994-01-03 Akihiko Ishida Pyridazinone derivatives and processes for preparing the same
CA2139088A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivatives, processes for preparing the same and synthetic intermediate of the same

Also Published As

Publication number Publication date
CN1107844A (zh) 1995-09-06
DE69418582D1 (de) 1999-06-24
SG48755A1 (en) 1998-05-18
EP0661273A1 (en) 1995-07-05
KR950017968A (ko) 1995-07-22
EP0661273B1 (en) 1999-05-19
DK0661273T3 (da) 1999-11-08
TW288012B (zh) 1996-10-11
MX9500251A (es) 1997-04-30
US5686452A (en) 1997-11-11
CA2138812A1 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
PT705833E (pt) Derivado de dc-89
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
AU9281198A (en) Benzofuran derivatives
ATE164582T1 (de) 1-methylcarbapenemderivate und verfahren zu ihrer herstellung
HU912649D0 (en) New tricyclic compounds production threreof and anti-microbic preparatives
NO304833B1 (no) Nye pyrrolokarbazoler
ATE180251T1 (de) Indan derivate und verfahren zu deren herstellung
DE69425266D1 (de) Optisch aktive imidazolidinon-derivate und verfahren zu deren herstellung
DK0601191T3 (da) Hidtil ukendt tetracyklisk forbindelse
ATE148128T1 (de) Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung
HU9600621D0 (en) Imidazolidinone derivative, acid-addition salt thereof, and remedy for senile dementia
DK0556813T3 (da) Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
ATE299489T1 (de) Aminderivate und verfahren zu ihrer herstellung
KR970001326A (ko) 2-나프타미드 유도체의 제조 방법 및 2-나프타미드 유도체 제조용 화합물
ATE98635T1 (de) Sterisch gehinderte aminoverbindungen und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties